Wells Fargo’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,821
| Closed | – | – | 7551 |
|
|
2022
Q3 | $0 | Buy |
1,821
+14
| +0.8% | – | ﹤0.01% | 7517 |
|
|
2022
Q2 | $1K | Buy |
1,807
+21
| +1% | +$12 | ﹤0.01% | 6403 |
|
|
2022
Q1 | $2K | Buy |
1,786
+1
| +0.1% | +$1 | ﹤0.01% | 6376 |
|
|
2021
Q4 | $5K | Sell |
1,785
-8,812
| -83% | -$24.7K | ﹤0.01% | 6168 |
|
|
2021
Q3 | $33K | Buy |
10,597
+8,793
| +487% | +$27.4K | ﹤0.01% | 5478 |
|
|
2021
Q2 | $7K | Sell |
1,804
-4,513
| -71% | -$17.5K | ﹤0.01% | 5920 |
|
|
2021
Q1 | $21K | Sell |
6,317
-18,475
| -75% | -$61.4K | ﹤0.01% | 5783 |
|
|
2020
Q4 | $83K | Buy |
24,792
+3,747
| +18% | +$12.5K | ﹤0.01% | 5255 |
|
|
2020
Q3 | $74K | Sell |
21,045
-3,937
| -16% | -$13.8K | ﹤0.01% | 5154 |
|
|
2020
Q2 | $114K | Buy |
24,982
+8,150
| +48% | +$37.2K | ﹤0.01% | 4967 |
|
|
2020
Q1 | $55K | Buy |
16,832
+8,699
| +107% | +$28.4K | ﹤0.01% | 5088 |
|
|
2019
Q4 | $50K | Sell |
8,133
-13,881
| -63% | -$85.3K | ﹤0.01% | 5258 |
|
|
2019
Q3 | $92K | Buy |
22,014
+5,968
| +37% | +$24.9K | ﹤0.01% | 5117 |
|
|
2019
Q2 | $211K | Buy |
+16,046
| New | +$211K | ﹤0.01% | 4771 |
|